Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
KMS Medisurgi's EPS (Basic) for the
six
months ended in Mar. 2026 was ₹0.04.
Its EPS (Basic) for the trailing twelve months (TTM) ended in Mar. 2026 was ₹0.74.
During the past 12 months, KMS Medisurgi's average EPS without NRIGrowth Rate was -44.40% per year.
During the past 3 years, the average EPS without NRIGrowth Rate was -25.50% per year.
During the past 5 years, the average EPS without NRIGrowth Rate was 11.70% per year.
During the past 10 years, the average EPS without NRIGrowth Rate was 4.00% per year.
During the past 13 years, KMS Medisurgi's highest 3-Year average EPS without NRI Growth Rate was 145.00% per year. The lowest was -45.70% per year. And the median was 23.80% per year.
KMS Medisurgi (BOM:540468) Earnings per Share (Diluted) Explanation
Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.
Be Aware
Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.
If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.
KMS Medisurgi Earnings per Share (Diluted) Related Terms
KMS Medisurgi Earnings per Share (Diluted) Historical Data
* Premium members only.
The historical data trend for KMS Medisurgi's Earnings per Share (Diluted) can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BOM:540468 vs ISRG, BDX, MDLN: Earnings per Share (Diluted) Comparison
For the Medical Instruments & Supplies subindustry, KMS Medisurgi's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
KMS Medisurgi PE Ratio vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, KMS Medisurgi's PE Ratio distribution charts can be found below:
* The bar in red indicates where KMS Medisurgi's PE Ratio falls into.
KMS Medisurgi Earnings per Share (Diluted) Calculation
Earnings Per Share (EPS) is the amount of earnings per outstanding share of the company's stock. In calculating earnings per share, the dividends of preferred stocks need to subtracted from the total net income first.
KMS Medisurgi's Earnings Per Share (Diluted) for the fiscal year that ended in Mar. 2026 is calculated as
Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the semi-annually data reported by the company within the most recent 12 months, which was ₹0.74
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Companies also reported diluted shares in their financial reports. Diluted shares include the shares of convertibles or warrants outstanding.
What does a Earnings per Share (Diluted) of ₹0.74 mean?
KMS Medisurgi (BOM:540468) has a Earnings per Share (Diluted) of ₹0.74 as of Mar. 2026. Diluted EPS equals net earnings divided by average shares outstanding, including dilutive securities. View historical data on KMS Medisurgi and its competitors.
Is KMS Medisurgi's Earnings per Share (Diluted) too high?
KMS Medisurgi's current Earnings per Share (Diluted) is ₹0.74. Overall, KMS Medisurgi has a GF Score™ of 79/100, reflecting its overall financial health beyond just this single metric.
How does KMS Medisurgi's Earnings per Share (Diluted) compare to ISRG and BDX?
KMS Medisurgi's Earnings per Share (Diluted) of ₹0.74 can be compared against companies in the Medical Devices & Instruments industry. The industry median Earnings per Share (Diluted) is 8.05. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Earnings per Share (Diluted) for a Medical Devices & Instruments company?
The median Earnings per Share (Diluted) among Medical Devices & Instruments companies is 8.05, based on 658 companies in the industry. Companies in the top quartile (top 25%) have a Earnings per Share (Diluted) significantly above this median, while those in the bottom quartile fall well below. However, Earnings per Share (Diluted) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Earnings per Share (Diluted) mean?
A high Earnings per Share (Diluted) can signal that a stock is expensive relative to its fundamentals. Diluted EPS equals net earnings divided by average shares outstanding, including dilutive securities. View historical data on KMS Medisurgi and its competitors. For the Medical Devices & Instruments industry, the median Earnings per Share (Diluted) is 8.05 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. KMS Medisurgi's current Earnings per Share (Diluted) is ₹0.74. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is KMS Medisurgi stock overvalued right now?
KMS Medisurgi (BOM:540468) has a current Earnings per Share (Diluted) of ₹0.74. The stock's GF Value™ is ₹111.52, compared to a current price of ₹132.80 — trading 19.1% above its estimated fair value. The current Earnings per Share (Diluted) is ₹0.74. KMS Medisurgi's overall GF Score™ is 79/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Earnings per Share (Diluted) calculated?
Earnings per Share (Diluted) is calculated from a company's financial statements. For KMS Medisurgi (BOM:540468), the current Earnings per Share (Diluted) is ₹0.74 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is KMS Medisurgi (BOM:540468) Overvalued in 2026?
Based on GuruFocus' analysis, KMS Medisurgi stock appears to be overvalued.
The current stock price of ₹132.80 is trading 19.1% above its estimated GF Value™ of ₹111.52.
Key valuation signals for BOM:540468:
Earnings per Share (Diluted): ₹0.74
GF Value™: ₹111.52 vs. price of ₹132.80 (19.1% above fair value)
No single metric tells the full story. See the BOM:540468 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
KMS Medisurgi Ltd manufactures surgical tapes and dressings for hospitals, institutions, trade associations, exporters, and importers. The company manufactures and undertakes job work of various substartes like non-woven fabrics, PU films, cotton fabrics, and taffeta silk fabrics with adhesive. The company's international presence includes Vietnam, Dubai, Europe, Australia, Cambodia, India, Africa, Philippines, Russia, Pakistan, Bangladesh, and the USA. The company derives revenue from the sale of goods.
79GF Score
Get the complete analysis for BOM:540468
Earnings per Share (Diluted) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:540468 has been successfully added to your 
